Antimicrobial and host defense peptides for therapeutic use against multidrug-resistant pathogens: New hope on the horizon

IDrugs

Volumn 12, Issue 6, 2009, Pages 376-380

  Bommarius, Bettina ^a   Kalman, Daniel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Innate immunity; MDR; Multidrug resistance; Pathogen; Peptide; Therapeutic

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BETA DEFENSIN; CATHELICIDIN; CECROPIN; CERAGENIN; CSA 13; CSA 54; HB 1345; HOST DEFENSE PEPTIDE; IMX 942; INDOLICIDIN; MAGAININ DERIVATIVE; MBI 594AN; MX 226; NZ 2114; OMIGANAN; OMIGARD; OPEBACAN; PEXIGANAN ACETATE; PLECTASIN; PMX 30063; PMX 60063; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPHEMUSIN; TALACTOFERRIN; UNCLASSIFIED DRUG;

ACNE; ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CATHETER INFECTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG HALF LIFE; ENTEROCOCCAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INNATE IMMUNITY; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MENINGOCOCCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; REVIEW; SEPSIS; SEXUALLY TRANSMITTED DISEASE; SKIN DISEASE; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; ULCER; WOUND INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

EID: 67650672160     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Giuliani A, Pirri G, Nicoletto F: Antimicrobial peptides: An overview of a promising class of therapeutics. Cent Eur J Biol (2007) 2(1):1-33.
2. Theuretzbacher U, Toney JH: Nature's clarion call of antibacterial resistance: Are we listening? Curr Opin Invest Drugs (2006) 7(2):158-166.
3. Hancock REW, Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 24(12):1551-1557.
4. Brogden KA: Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev (2005) 3(3):238-250.
5. Yeaman MR, Yount NY: Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev (2003) 55(1):27-55.